Edition:
India

People: Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

30.86CAD
13 Sep 2019
Change (% chg)

$-0.52 (-1.66%)
Prev Close
$31.38
Open
$31.62
Day's High
$31.87
Day's Low
$30.72
Volume
734,314
Avg. Vol
705,434
52-wk High
$36.52
52-wk Low
$23.60

Papa, Joseph 

Mr. Joseph C. (Joe) Papa is Chairman of the Board, Chief Executive Officer of the Company. He has been Chairman of the Board and Chief Executive Officer of the Company since May 2016. Mr. Papa has more than 35 years of experience in the pharmaceutical, healthcare and specialty pharmaceutical industries, including 20 years of branded prescription drug experience. He served as the CEO of Perrigo Company plc (“Perrigo”) from 2006 to 2016, where he was also Chairman from 2007 to 2016. Prior to joining Perrigo, Mr. Papa served from December 2004 to October 2006 as Chairman and CEO of the Pharmaceutical and Technologies Services segment of Cardinal Health, Inc. From 2001 to 2004, he served as President and Chief Operating Officer of Watson Pharmaceuticals, Inc. (“Watson”). Prior to joining Watson, Mr. Papa has also held management positions at DuPont Pharmaceuticals, Pharmacia/Searle and Novartis AG. Mr. Papa was a director of Smith & Nephew, a developer of advanced medical devices, from August 2008 to April 2018.

Basic Compensation

Total Annual Compensation, USD 1,500,000
Restricted Stock Award, USD 7,344,930
Long-Term Incentive Plans, USD --
All Other, USD 5,896,120
Fiscal Year Total, USD 14,741,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joseph Papa

14,741,000

Paul Herendeen

6,400,810

Thomas Appio

4,386,600

Joseph Gordon

1,962,200

William Humphries

8,434,210

Mark McKenna

--
As Of  31 Dec 2018